Zhejiang Xianju Pharmaceutical Co.,Ltd. (SHE: 002332)

Market Cap	11.58B
Revenue (ttm)	4.14B
Net Income (ttm)	601.00M
Shares Out	989.20M
EPS (ttm)	0.60
PE Ratio	19.50
Forward PE	16.85
Dividend	0.30 (2.56%)
Ex-Dividend Date	Jun 5, 2024

Volume	4,646,980
Open	12.03
Previous Close	11.71
Day's Range	11.64 - 12.03
52-Week Range	8.44 - 13.40
Beta	-0.34
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 25, 2024

About Zhejiang Xianju Pharmaceutical Co.,Ltd.

Zhejiang Xianju Pharmaceutical Co.,Ltd. manufactures and sells steroids and hormones worldwide. The company offers gynecological, anesthesia, respiratory, dermatology, generic drug, and other products; and active pharmaceutical ingredients (API), such as corticosteroids, sex hormone, progesterone, non-hormone series, newchem API, and intermediates products. The company was founded in 1972 and is headquartered in Xianju, China.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1972
• Employees: 3,281
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 002332

Financial Performance

In 2023, Zhejiang Xianju Pharmaceutical Co.,Ltd.'s revenue was 4.12 billion, a decrease of -5.85% compared to the previous year's 4.38 billion. Earnings were 563.08 million, a decrease of -24.86%.